In the United States, cosmetics — including body wash — are regulated by the FDA primarily under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and, since December 2022, the Modernization of Cosmetics Regulation Act (MoCRA). Here is what a private label brand launching a retinol glycolic acid body wash needs to be aware of.
MoCRA facility registration is required for every cosmetic manufacturing and processing facility as of December 29, 2023. Your co-manufacturer must be registered; confirm this in writing before signing a development agreement. Facilities that do not register are out of compliance, and as of 2024, the FDA has begun enforcement. Your brand itself must also register products electronically with the FDA if you are the responsible party (the entity whose name appears on the label).
Cosmetic product listing under MoCRA requires you to submit product name, a list of ingredients (INCI format), the type of product (rinse-off body wash), and the name/address of the responsible party. This is a one-time submission per product, with updates required when the formula changes.
Safety substantiation is not optional — MoCRA codifies the requirement that cosmetics be adequately substantiated for safety. For a product with retinol and glycolic acid, your safety substantiation file should include: stability data, preservative efficacy test results, a safety assessment signed by a qualified professional (typically a cosmetic chemist or toxicologist), and any applicable sensitization/irritation testing data.
Label requirements under FDA rules include: product identity (e.g., "Exfoliating Body Wash"), net quantity of contents, distributor name and address, ingredient list in INCI descending order of concentration, and any required warnings. For glycolic acid products above 10%, FDA guidance suggests including a UV sensitivity warning. For retinol products marketed to pregnant consumers, a precautionary pregnancy warning is strongly advised.
Claims discipline matters enormously. A body wash is a cosmetic; the moment your marketing claims cross into drug territory — "treats acne," "reduces wrinkles by X%," "clinically proven" — you risk FDA classification as a drug, which triggers a completely different and far more expensive regulatory pathway. Your manufacturer's cosmetic chemist and your legal counsel should review all label and marketing copy before launch.
Prop 65 in California is relevant if you are selling there: retinyl palmitate is listed as a Prop 65 chemical. Most brands include a Prop 65 warning on products sold in California as a precaution. AJ Cosmo Labs connects founders with manufacturers who have in-house regulatory expertise to help navigate these requirements during the development phase, not after the product is already printed and filled.
Ingredients in this answer: Glycolic Acid · Retinol · Retinyl Palmitate
Read the full guide on Private Label Retinol Glycolic Acid Body Wash Manufacturer →